Waldenström's macroglobulinemia epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Waldenström's macroglobulinemia}} | {{Waldenström's macroglobulinemia}} | ||
{{CMG}}{{AE}}{{MGS}} | {{CMG}}{{AE}}{{MGS}}{{RAK}} | ||
==Overview== | ==Overview== | ||
The prevalence of | The prevalence of Waldenström macroglobulinemia is estimated to be 1500 cases in United States annually.<ref name="ncbi">Waldenström’s macroglobulinemia | ||
Wikipedia (2015) https://en.wikipedia.org/wiki/Waldenström%27s_macroglobulinemia#cite_note-Cheson-1 Accessed on November, 6 2015</ref> Waldenström's macroglobulinemia represents 1% of all hematological cancers.<ref name="wiki">Molecular pathogenesis of Waldenström’s macroglobulinemia NCBI (2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436227/ Accessed on November, 6 2015</ref> | Wikipedia (2015) https://en.wikipedia.org/wiki/Waldenström%27s_macroglobulinemia#cite_note-Cheson-1 Accessed on November, 6 2015</ref> Waldenström's macroglobulinemia represents 1% of all hematological cancers.<ref name="wiki">Molecular pathogenesis of Waldenström’s macroglobulinemia NCBI (2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436227/ Accessed on November, 6 2015</ref> | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
* The prevalence of | * The prevalence of Waldenström macroglobulinemia is estimated to be 1500 cases in United States annually.<ref name="ncbi">Waldenström’s macroglobulinemia | ||
Wikipedia (2015) https://en.wikipedia.org/wiki/Waldenström%27s_macroglobulinemia#cite_note-Cheson-1 Accessed on November, 6 2015</ref> | Wikipedia (2015) https://en.wikipedia.org/wiki/Waldenström%27s_macroglobulinemia#cite_note-Cheson-1 Accessed on November, 6 2015</ref> | ||
===Incidence=== | ===Incidence=== | ||
* World-wide, age-adjusted incidence of | * World-wide, age-adjusted incidence of Waldenström macroglobulinemia is 0.38 cases per 100,000 persons annually, increasing with age to 2.85 in patients above 80 years.<ref name="pmid23901022">{{cite journal| author=Monge J, Braggio E, Ansell SM| title=Genetic factors and pathogenesis of Waldenström's macroglobulinemia. | journal=Curr Oncol Rep | year= 2013 | volume= 15 | issue= 5 | pages= 450-6 | pmid=23901022 | doi=10.1007/s11912-013-0331-7 | pmc=PMC3807757 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23901022 }} </ref> | ||
===Age=== | ===Age=== | ||
Revision as of 19:27, 30 October 2018
|
Waldenström's macroglobulinemia Microchapters |
|
Differentiating Waldenström's macroglobulinemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Waldenström's macroglobulinemia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Waldenström's macroglobulinemia epidemiology and demographics |
|
FDA on Waldenström's macroglobulinemia epidemiology and demographics |
|
CDC on Waldenström's macroglobulinemia epidemiology and demographics |
|
Waldenström's macroglobulinemia epidemiology and demographics in the news |
|
Blogs on Waldenström's macroglobulinemia epidemiology and demographics |
|
Directions to Hospitals Treating Waldenström's macroglobulinemia |
|
Risk calculators and risk factors for Waldenström's macroglobulinemia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]Roukoz A. Karam, M.D.[3]
Overview
The prevalence of Waldenström macroglobulinemia is estimated to be 1500 cases in United States annually.[1] Waldenström's macroglobulinemia represents 1% of all hematological cancers.[2]
Epidemiology and Demographics
Prevalence
- The prevalence of Waldenström macroglobulinemia is estimated to be 1500 cases in United States annually.[1]
Incidence
- World-wide, age-adjusted incidence of Waldenström macroglobulinemia is 0.38 cases per 100,000 persons annually, increasing with age to 2.85 in patients above 80 years.[3]
Age
- The incidence of Waldenström's macroglobulinemia increases after 50 years of age.[4]
- The median age at diagnosis is 65 years.[5]
Gender
- Men are more likely than women to develop Waldenström macroglobulinemia.[5]
Race
- Waldenström's macroglobulinemia is more common among whites.[5]
References
- ↑ 1.0 1.1 Waldenström’s macroglobulinemia Wikipedia (2015) https://en.wikipedia.org/wiki/Waldenström%27s_macroglobulinemia#cite_note-Cheson-1 Accessed on November, 6 2015
- ↑ Molecular pathogenesis of Waldenström’s macroglobulinemia NCBI (2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436227/ Accessed on November, 6 2015
- ↑ Monge J, Braggio E, Ansell SM (2013). "Genetic factors and pathogenesis of Waldenström's macroglobulinemia". Curr Oncol Rep. 15 (5): 450–6. doi:10.1007/s11912-013-0331-7. PMC 3807757. PMID 23901022.
- ↑ Waldenström's macroglobulinemia. American Cancer Society (2015)http://www.cancer.org/cancer/waldenstrommacroglobulinemia/detailedguide/waldenstrom-macroglobulinemia-risk-factors Accessed on November 6, 2015
- ↑ 5.0 5.1 5.2 Wang H, Chen Y, Li F, Delasalle K, Wang J, Alexanian R; et al. (2012). "Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study". Cancer. 118 (15): 3793–800. doi:10.1002/cncr.26627. PMID 22139816.